These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 4218716

  • 1. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
    Appelboom T, Kahn MF, Peltier AP, de SEZE S.
    Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
    [No Abstract] [Full Text] [Related]

  • 2. [Sharp's syndrome: a new entity amongst the connective tissue diseases?].
    Kahn MF, Peltier AP, Appelboom T.
    Nouv Presse Med; 1975 Jun 21; 4(25):1863-5. PubMed ID: 1080278
    [Abstract] [Full Text] [Related]

  • 3. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O, Haïm T.
    Nouv Presse Med; 1982 Oct 09; 11(39):2891-4. PubMed ID: 6755388
    [Abstract] [Full Text] [Related]

  • 4. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.
    Maddison PJ, Mogavero H, Reichlin M.
    J Rheumatol; 1978 Oct 09; 5(4):407-11. PubMed ID: 310884
    [Abstract] [Full Text] [Related]

  • 5. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O, Haim T, Ryckewaert A.
    Rev Rhum Mal Osteoartic; 1983 Apr 09; 50(4):261-6. PubMed ID: 6348931
    [Abstract] [Full Text] [Related]

  • 6. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
    Sharp GC, Irvin WS, May CM, Holman HR, McDuffie FC, Hess EV, Schmid FR.
    N Engl J Med; 1976 Nov 18; 295(21):1149-54. PubMed ID: 1086429
    [Abstract] [Full Text] [Related]

  • 7. Mixed connective tissue disease.
    Minkin W, Rabhan N.
    Arch Dermatol; 1976 Nov 18; 112(11):1535-8. PubMed ID: 1086651
    [Abstract] [Full Text] [Related]

  • 8. [The clinical significance of soluble nuclear antigen specific antibodies (author's transl)].
    Peltier AP, Gaudreau A, Amor B, Kahn MF, Ryckewaert A, Sany J, Haim T.
    Nouv Presse Med; 1978 May 27; 7(21):1813-8. PubMed ID: 307737
    [Abstract] [Full Text] [Related]

  • 9. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
    Uchida K, Kondo H, Kashiwazaki S.
    Ryumachi; 1984 Aug 27; 24(4):241-9. PubMed ID: 6334895
    [No Abstract] [Full Text] [Related]

  • 10. Symptomatology and diagnosis in connective tissue disease. Antibodies to extractable ribonucleoprotein in 123 patients reacting with cell nuclei in the immunofluorescence test.
    Jonsson J.
    Scand J Rheumatol; 1976 Aug 27; 5(3):177-83. PubMed ID: 790556
    [Abstract] [Full Text] [Related]

  • 11. [Anti-Scl-70 antibodies in systemic scleroderma].
    Le Thi Huong, Sauvaget F, Johanet C, De Gennes C, Raguin G, Abuaf N, Blétry O, Guillevin L, Homberg JC, Godeau P.
    Ann Dermatol Venereol; 1990 Aug 27; 117(2):103-7. PubMed ID: 2111650
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
    Levo Y, Lotan C.
    Isr J Med Sci; 1982 Feb 27; 18(2):287-9. PubMed ID: 6978327
    [No Abstract] [Full Text] [Related]

  • 16. Proteins responsible for anticentromere activity found in the sera of patients with CREST-associated Raynaud's phenomenon.
    Kremer L, Alvaro-Gracia JM, Ossorio C, Avila J.
    Clin Exp Immunol; 1988 Jun 27; 72(3):465-9. PubMed ID: 3048807
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Autoallergic diseases. II].
    Feo F.
    Minerva Med; 1978 Oct 27; 69(51):3546-9. PubMed ID: 83553
    [No Abstract] [Full Text] [Related]

  • 19. Antinuclear antibodies as immunologic markers for a benign subset and different clinical characteristics of scleroderma.
    Kleinsmith DM, Heinzerling RH, Burnham TK.
    Arch Dermatol; 1982 Nov 27; 118(11):882-5. PubMed ID: 6753766
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of antibodies to ribonucleoprotein.
    Cohen ML, Dawkins B, Dawkins RL, Owen ET.
    Ann Rheum Dis; 1979 Feb 27; 38(1):74-8. PubMed ID: 312058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.